Oncology & Cancer

CDC: Recent decline seen in high-grade cervical lesions

(HealthDay)—The number of cervical precancers (CIN2+ cases) in the United States declined from 2008 to 2016, likely in part because of prevention with the human papillomavirus (HPV) vaccine, according to research published ...

Oncology & Cancer

Why the HPV vaccine is more important than ever

(HealthDay)—HPV, the human papillomavirus, is the most common sexually transmitted infection in the United States, with 14 million new cases each year.

Oncology & Cancer

Cervical microbiome may promote high-grade precancerous lesions

Infections with a Human Papillomavirus (HPV) cause 99 percent of cervical cancer cases, and the disease's first sign is often the appearance of precancerous lesions on a woman's cervix. But bacteria may play an important ...

Oncology & Cancer

Study 'strongly supports' extending cervical screening intervals

Screening for high risk human papillomavirus (HR-HPV) infection works well in practice and is more sensitive than cytology (smear) testing—offering greater protection against cervical cancer, confirm researchers in The ...

Diseases, Conditions, Syndromes

HPV vaccine even helps women who didn't get it: study

(HealthDay)—The vaccine against human papillomavirus (HPV) is highly effective in young women—and may even offer some protection to those who don't get it, a new study suggests.

Health

Messages for increasing parental confidence in HPV vaccine ID'd

(HealthDay)—Providing information on the benefits of vaccination, including cancer prevention, and avoiding expressing urgency to vaccinate can increase parent confidence in human papillomavirus (HPV) vaccination, according ...

page 17 from 40